Moderna Trial | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34813 of 34823  at  5/26/2020 4:25:10 PM  by

The Rooster


 In response to msg 34812 by  adenylyl
view thread

Re: Moderna Trial

 Adenylyl:
 
All doses groups get it twice according to the P1 study design:
 
 
"The Phase 1 study is evaluating the safety and immunogenicity of three dose levels of mRNA-1273 (25, 100, 250 μg) administered on a two-dose vaccination schedule, given 28 days apart."


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 179
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34814 Re: Moderna Trial adenylyl 0 5/26/2020 4:56:05 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...